• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates
Home » Medtronic to hold onto Hawkins for one more year

Medtronic to hold onto Hawkins for one more year

December 31, 2010 By MedCity News

MDT logo

Bill Hawkins, the outgoing CEO of Medtronic Inc. (NYSE:MDT), will remain at the company for one year after stepping down in April.

He will receive on top of his current annual salary of $1.25 million an expected $3.8 million in separation pay, according to a Securities & Exchnage Commission filing.

Medtronic announced in early December that Hawkins would leave after three years of leading the company. The Fridley, Minn.-based maker of new innovative medical devices said it would seek an outside candidate for chief executive officer.

MedCity News logo

Hawkins’ transition role will largely be as a consultant. He won’t be required to report to work, but instead make himself available to advise on everything from litigation and community affairs to talent retention and industry leadership, according to the separation letter filed with the SEC.

Hawkins will also take with him one of Medtronic’s 4,500 iPads. In the separation agreement Hawkins is allowed to keep a “cellular phone, iPad and laptop computer.” There was no mention of brand of phone or laptop. His stock options and restricted stock grants will also continue to vest during his transition year. His total compensation was about $9.6 million in the previous fiscal year.

While Hawkins’ tenure was relatively short, he left an indelible mark on the world’s largest maker of medical devices.

Here’s a look back on the Hawkins era at Medtronic.

August 2007: Medtronic names Hawkins CEO. He previously served as chief operating officer and president of the company’s vascular unit. Prior to Medtronic, Hawkins was president and CEO of Novoste Corp., a firm that specializes in using radiation to treat the reclotting of blood vessels.

October 2007: Medtronic issues a worldwide recall of its next generation Sprint Fidelis wires, which had a faulty design that may have contributed to 13 deaths.

The recall was “probably the toughest decision of my life,” Hawkins later told Chief Executive magazine.

“It was not black and white,” he said. “It was all statistics and probabilities – not that we had had [a significant number] of failures. Plus, we had to consider the risk of people whose lives depend upon the device getting concerned and wanting to have it extracted, which could have a higher mortality risk than leaving it in.”

Sprint Fidelis cast an enormous shadow over Hawkins’ tenure. But the company eventually won a landmark Supreme Court decision that protected medical device makers from liability if the Food and Drug Administration had approved their products.

Medtronic recently announced that it would pay $268 million to settle all Sprint Fidelis-related lawsuits.

December 2008: Medtronic pays $380 million to purchase CryoCath Technologies Inc. The Canadian company makes catheters and balloons that restore normal electrical signals in the heart by freezing the tissue or pathways behind the irregular quivering.

The deal epitomized Hawkins’ “tuck-in” acquisition strategy, which favored smaller deals that could replenish Medtronic’s product pipeline and/or goose sales.

The FDA recently approved CryoCath’s Arctic Front therapy for use in the United States.

Over the next few years, Medtronic paid $700 million for CoreValve, $325 million for Ventor Technologies, $123 million for Osteotech, $370 million for ATS Medical, and $800 million for Ardian.

August 2009: Medtronic reorganizes its business operations, combining cardiac rhythm disease management, cardiovascular, and Physio-Control into one operating unit and spinal and biologics, neuromodulation, diabetes and Surgical Technologies Group into another.

The reorganization was a key component to Hawkins’ “One Medtronic” strategy that emphasized profitability and cost control through greater integration and cooperation between the company’s traditionally independent business units.

August 2010: Medtronic opens a new patient care center in Beijing, a symbol of the increasing clout of China and the rest of the company’s global operations.

Over 40 percent of Medtronic’s yearly revenue now originates overseas, led by China, which generates about $500 million in annualized sales and an annual growth rate of 20 percent.

Filed Under: Business/Financial News, News Well

In case you missed it

  • Google Health hires FDA’s chief digital health officer
  • ApiJect picks up $111M investment from Royalty Pharma, Jefferies
  • Expect more heart and lung failure years after COVID, Abbott’s heart failure CMO says
  • Teleflex wins Health Canada nod for Manta vascular closure device
  • Study shows strong performance, improved outcomes with Medtronic Evolut TAVR
  • New FDA clearance expands indications for Xact Robotics’ ablation system
  • Medtronic’s Resolute Onyx drug-eluting stent demonstrates strong safety, efficacy
  • Avanos Medical recall of Cortrak 2 enteral access system is Class I
  • Jabil launches Qfinity reusable auto-injector
  • Launching your med device: A strategy & execution cross-functional guide
  • FDA allows booster dose Pfizer-BioNTech COVID-19 vaccine in children 5 to 11
  • FDA clears DePuy Synthes’ Inhance for total shoulder arthroplasty
  • Henry Schein hires former Medline veteran to drive ‘One Distribution’ push
  • FDA authorizes Labcorp’s non-prescription COVID-19 test that also detects flu, RSV
  • Massachusetts is competing for ARPA-H biomedical research center
  • Vivasure raises $23M initial Series D tranche; could reach up to $54M
  • Exactech announces breakthrough nod for JointMedica’s hip resurfacing system

RSS From Medical Design & Outsourcing

  • Google Health hires FDA’s chief digital health officer
    Former FDA Chief Digital Health Officer of Global Strategy and Innovation Bakul Patel has started a new job with Google after 13 years with the regulatory agency. Patel became senior director, global digital health strategy and regulatory for Google Health earlier this month, he said on LinkedIn. Patel recounted highlights of his “incredible journey since… […]
  • Expect more heart and lung failure years after COVID, Abbott’s heart failure CMO says
    Two years into the COVID-19 pandemic, we know more than ever about the SARS-CoV-2 virus and how quickly it moves to ravage the human body. What remains to be seen is how the virus — and perhaps more importantly, our immune system’s response to it — will affect the health of people long after infection,… […]
  • FDA moves forward with Voluntary Improvement Program to bolster medical device quality
    Kathryn Burke, Emergo Group The U.S. Food and Drug Administration has issued new draft guidance to establish a full-blown voluntary program for improving quality-related processes in medical device manufacturing following promising results of a pilot program. The FDA guidance stems from a pilot undertaken by the agency along with the Medical Device Innovation Consortium (MDIC) in 2018.… […]
  • How Minnetronix Medical helped Lazurite with its wireless surgical camera
    Minnetronix Medical (St. Paul, Minnesota) has played an important development and manufacturing partner role with Lazurite’s wireless surgical camera system. It’s been nearly two months since Lazurite (formerly Indago) announced FDA 510(k) clearance of its ArthroFree system. ArthroFree combines proprietary low-heat, high-intensity Meridiem light engine technology with advanced camera, battery and wireless transmission technologies and… […]
  • Instron releases TrendTracker data analysis workflow platform
    Instron announced that it released the TrendTracker module in Bluehill Central for accelerating data analysis workflows. Norwood, Massachusetts-based Instron designed TrendTracker with an intuitive interface to improve the data analysis workflow of single or multi-location materials testing laboratories. According to a news release, the platform features quick searching and the ability to display and analyze… […]
  • Henry Schein hires former Medline veteran to drive ‘One Distribution’ push
    Henry Schein (Nasdaq:HSIC) today named Dirk Benson as VP and chief commercial officer of the medical device manufacturer and distributor’s North America Distribution Group (NADG). Melville, New York-based Henry Schein is the world’s largest provider of health care supplies and services for office-based dental and medical practitioners, and NADG is the company’s largest business group. The… […]
  • The road to a robot: Medtronic’s development process for its Hugo RAS system
    Elephants are the perfect analogy for surgical robotics, Medtronic (NYSE:MDT) VP of Marketing for Surgical Robotics Mike Stow says. Speaking on the “Road to a robot: Designing technology to address unmet needs & barriers” panel at DeviceTalks Boston last week, Stow explained that elephants are big, taking up a lot of space and that they eat a lot, making… […]
  • iRhythm stays silent on federal grand jury subpoenas
    More than one year after receiving the first of two federal grand jury subpoenas seeking information about its products and communications with the FDA, iRhythm Technologies has said little publicly about the matter. It would have been easy to miss the San Francisco-based cardiac monitor maker’s initial disclosure last summer. iRhythm (Nasdaq:IRTC) was without a… […]
  • How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
    A lot of talk around Dexcom (Nasdaq:DXCM) in the last couple of years has centered around its next-generation G7 continuous glucose monitor. The latest iteration of the company’s CGM platform has already garnered CE mark this year and awaits FDA approval, with some expectations for that to come after the American Diabetes Association’s Scientific Sessions next month. The company also presented… […]
  • Texas power grid struggles in heat one year after record cold stopped semiconductor plants
    A heatwave in Texas took at least six power plants offline Friday, with high temperatures forecasted to blaze throughout this week. A record cold snap in February 2021 took NXP Semiconductors and Samsung chip fabrication facilities offline for weeks, contributing to a global semicondcutor shortage that is still throttling medical device production. There’s no indication… […]
  • How Stryker includes users for product design in the digital age
    Medical device developers and manufacturers like Stryker (NYSE:SYK) are changing how they approach design as digital technology becomes more crucial. Four Stryker executives shared how the Kalamazoo, Michigan–based orthopedic device giant is thinking differently about medical product development and how health care providers and patients will ultimately use them. The DeviceTalks Boston panel of Stryker… […]

Leave a Reply

You must be logged in to post a comment.

Primary Sidebar

DeviceTalks Weekly

May 13, 2022
Our Pre-Post-DeviceTalks Boston episode, also MedtronicTalks replay with Gastro CMO Austin Chiang
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS